| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.3811 | 34 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.8411 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.555 | 39 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.2448 | 38 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.4456 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.2443 | 38 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.8167 | 26 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.078 | 41 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.1484 | 33 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.9377 | 32 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.5423 | 20 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.7174 | 21 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.5671 | 25 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.5577 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.4663 | 39 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.362 | 11 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.8204 | 59 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.5926 | 39 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.5184 | 47 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.5332 | 47 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.0716 | 27 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.4435 | 43 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.6484 | 35 |